Spots Global Cancer Trial Database for Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Official Title: An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rare Tumors of Neuroendocrine Origin
Study ID: NCT00958841
Interventions
Study Description
Brief Summary: This study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cedars Sinai Medical Center Cedars Sinai 4, Los Angeles, California, United States
Cedars Sinai Medical Center The Pituitary Center (3), Los Angeles, California, United States
Stanford University Medical Center SC, Stanford, California, United States
Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5), Boston, Massachusetts, United States
Mount Sinai School of Medicine Study Coordinator, New York, New York, United States
Swedish Medical Center Dept.ofSwedishMedicalCtr.(2), Seattle, Washington, United States
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Westmead, New South Wales, Australia
Novartis Investigative Site, Fitzroy, Victoria, Australia
Novartis Investigative Site, Fortaleza, CE, Brazil
Novartis Investigative Site, Belo Horizonte, MG, Brazil
Novartis Investigative Site, Botucatu, SP, Brazil
Novartis Investigative Site, Halifax, Nova Scotia, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Angers, , France
Novartis Investigative Site, Bron Cedex, , France
Novartis Investigative Site, Le Kremlin Bicetre, , France
Novartis Investigative Site, Lille Cedex, , France
Novartis Investigative Site, Marseille cedex 05, , France
Novartis Investigative Site, Pessac Cedex, , France
Novartis Investigative Site, Reims, , France
Novartis Investigative Site, Strasbourg, , France
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Erlangen, , Germany
Novartis Investigative Site, Frankfurt, , Germany
Novartis Investigative Site, Muenchen, , Germany
Novartis Investigative Site, Ulm, , Germany
Novartis Investigative Site, Würzburg, , Germany
Novartis Investigative Site, Ancona, AN, Italy
Novartis Investigative Site, Cona, FE, Italy
Novartis Investigative Site, Padova, PD, Italy
Novartis Investigative Site, Pisa, PI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, México, Distrito Federal, Mexico
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Saint-Petersburg, , Russian Federation
Novartis Investigative Site, Malaga, Andalucia, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Bangkok, , Thailand
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
